UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 20, 2019
Accession Number:
0001213900-19-023736
Submission Type:
POS AM
CIK:
0001498382
Company Name:
DelMar Pharmaceuticals, Inc.
File Number:
333-232931